T May

Summary

Affiliation: CHU de Nancy
Country: France

Publications

  1. doi request reprint Antibiolor, the Lorraine antibiology network: update on 7 years of activity
    T May
    Service de Maladies Infectieuses et Tropicales, CHU de Nancy, 54500 Vandœuvre, France
    Med Mal Infect 42:355-60. 2012
  2. ncbi request reprint [Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]
    T May
    Service de Maladies Infectieuses et Tropicales, Hopital Brabois, Vandoeuvre les Nancy
    Presse Med 33:1487-92. 2004
  3. doi request reprint [New antibiotics]
    T May
    Service de Maladies Infectieuses, Hopitaux de Brabois, rue du Morvan, Tour Drouet, 54500 Vandoeuvre les Nancy, France
    Rev Med Interne 29:S11-2. 2008
  4. doi request reprint Relevance of fluoroquinolone use in a French teaching hospital
    L Rughoo
    Pharmacy, Hôpital Brabois Adultes, CHU de Nancy, Allee du Morvan, 54511 Vandœuvre les Nancy, France
    Med Mal Infect 42:608-14. 2012
  5. doi request reprint [Impact of corrective measures on fluoroquinolones prescriptions for urinary tract infections during a 2-round relevance study]
    V Gendrin
    CHU de Nancy, Hopitaux de Brabois, Maladies Infectieuses et Tropicales, 54500 Vandoeuvre les Nancy, France
    Presse Med 41:e10-4. 2012
  6. doi request reprint [Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn]
    E Desmots
    Service des Maladies Infectieuses et Tropicales, Hopitaux de Brabois, CHU de Nancy, Allee du Morvan, 54500 Vandœuvre lès Nancy, France
    Pathol Biol (Paris) 59:122-6. 2011
  7. doi request reprint Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients
    Claudine Duvivier
    AP HP, Groupe Hospitalier Pitie Salpetriere, Service de Maladies Infectieuses et Tropicales, Paris, France
    AIDS 23:817-24. 2009
  8. ncbi request reprint [<< Mortalité 2005 >> study in collaboration with Mortavic]
    T May
    Service de Maladies Infectieuses et Tropicales, Hopital Brabois, Vandoeuvre les Nancy, France
    Med Mal Infect 35:S28-30. 2005
  9. doi request reprint [Relevance of fluoroquinolone use in Lorraine: results of the first survey]
    T Doco-Lecompte
    Maladies Infectieuses et Tropicales, Hopitaux de Brabois, CHU de Nancy, Allee du Morvan, Vandoeuvre les Nancy, France
    Med Mal Infect 40:106-11. 2010
  10. doi request reprint 15 years of antibiotic stewardship policy in the Nancy Teaching Hospital
    S Bevilacqua
    Service des Maladies Infectieuses et Tropicales, CHU Nancy, Hopitaux de Brabois, bâtiment P Canton, rue du Morvan, Vandœuvre lès Nancy, Nancy, France
    Med Mal Infect 41:532-9. 2011

Detail Information

Publications34

  1. doi request reprint Antibiolor, the Lorraine antibiology network: update on 7 years of activity
    T May
    Service de Maladies Infectieuses et Tropicales, CHU de Nancy, 54500 Vandœuvre, France
    Med Mal Infect 42:355-60. 2012
    ..The objective of the study was to assess the activity of the Antibiolor network, created in 2003, to promote antibiotic stewardship in Lorraine, and comply with the French Ministry guidelines issued in May 2002...
  2. ncbi request reprint [Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]
    T May
    Service de Maladies Infectieuses et Tropicales, Hopital Brabois, Vandoeuvre les Nancy
    Presse Med 33:1487-92. 2004
    ..To analyse the causes of death among HIV-infected adults in France in the year 2000...
  3. doi request reprint [New antibiotics]
    T May
    Service de Maladies Infectieuses, Hopitaux de Brabois, rue du Morvan, Tour Drouet, 54500 Vandoeuvre les Nancy, France
    Rev Med Interne 29:S11-2. 2008
  4. doi request reprint Relevance of fluoroquinolone use in a French teaching hospital
    L Rughoo
    Pharmacy, Hôpital Brabois Adultes, CHU de Nancy, Allee du Morvan, 54511 Vandœuvre les Nancy, France
    Med Mal Infect 42:608-14. 2012
    ..The objective of our study was to assess the good use of fluoroquinolone (FQ) in a French teaching hospital by a two round relevance review before and after proposal for better use of FQ prescriptions...
  5. doi request reprint [Impact of corrective measures on fluoroquinolones prescriptions for urinary tract infections during a 2-round relevance study]
    V Gendrin
    CHU de Nancy, Hopitaux de Brabois, Maladies Infectieuses et Tropicales, 54500 Vandoeuvre les Nancy, France
    Presse Med 41:e10-4. 2012
    ..Evaluating the impact of corrective measures on fluoroquinolones (FQ) prescriptions for urinary tract infections (UTI) during a 2-round relevance study on a regional scale...
  6. doi request reprint [Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn]
    E Desmots
    Service des Maladies Infectieuses et Tropicales, Hopitaux de Brabois, CHU de Nancy, Allee du Morvan, 54500 Vandœuvre lès Nancy, France
    Pathol Biol (Paris) 59:122-6. 2011
    ..The objective was to evaluate the good use of fluoroquinolones in a hospital with a relevance review in the context of an approach to evaluation of professional practices at the regional level initiated by the Antibiolor network...
  7. doi request reprint Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients
    Claudine Duvivier
    AP HP, Groupe Hospitalier Pitie Salpetriere, Service de Maladies Infectieuses et Tropicales, Paris, France
    AIDS 23:817-24. 2009
    ..To evaluate the change in bone mineral density (BMD) at specific sites in patients initiating antiretroviral therapy in a substudy of the ANRS 121 trial...
  8. ncbi request reprint [<< Mortalité 2005 >> study in collaboration with Mortavic]
    T May
    Service de Maladies Infectieuses et Tropicales, Hopital Brabois, Vandoeuvre les Nancy, France
    Med Mal Infect 35:S28-30. 2005
  9. doi request reprint [Relevance of fluoroquinolone use in Lorraine: results of the first survey]
    T Doco-Lecompte
    Maladies Infectieuses et Tropicales, Hopitaux de Brabois, CHU de Nancy, Allee du Morvan, Vandoeuvre les Nancy, France
    Med Mal Infect 40:106-11. 2010
    ..The Antibiolor network assessed the good use of fluoroquinolones (FQ) in the French Lorraine region by a relevance review...
  10. doi request reprint 15 years of antibiotic stewardship policy in the Nancy Teaching Hospital
    S Bevilacqua
    Service des Maladies Infectieuses et Tropicales, CHU Nancy, Hopitaux de Brabois, bâtiment P Canton, rue du Morvan, Vandœuvre lès Nancy, Nancy, France
    Med Mal Infect 41:532-9. 2011
    ..The authors report the results of a 15-year antibiotic stewardship policy in the Nancy Teaching Hospital and assess the impact of reinforcing this policy on antibiotic consumption...
  11. ncbi request reprint Hepatitis B e antigen positive mother hepatitis B e antigen long persistence in her non-infected baby
    D Selton
    Department of Neonatology, Maternite Regionale, 10 Rue du Docteur Heydenreich, 54042 Nancy, France
    Acta Paediatr 96:314-6. 2007
    ..This infant had a hepatitis B e antigen (HBeAg) in the serum until 6 months of age. Serial sera samples were analysed for HBV markers. No breakthrough of HBV infection was detected. The origin of this HBV marker has been questioned...
  12. doi request reprint Antifungal agents use in a French administrative region
    M Abdel Fattah
    Service des Maladies Infectieuses et Tropicales, Hopital Brabois, CHU de Nancy, Allee du Morvan, 54500 Vandœuvre lès Nancy, France
    Med Mal Infect 45:279-85. 2015
    ..In December 2011, the Lorraine Regional Health Agency commissioned the Antibiolor network to evaluate costly antifungal agent stewardship using as reference regional, French, and international recommendations...
  13. doi request reprint [Study of new HIV infection between 2000 and 2007 in the north and east of France]
    S Henard
    COREVIH Lorraine Champagne Ardennes, Hopitaux de Brabois, Allee du Morvan, 54500 Vandoeuvre les Nancy, France
    Med Mal Infect 40:517-23. 2010
    ..In France, since 2003, all new HIV infection must be reported. Data collected with the declaration system is not exhaustive and only concerns epidemiological data...
  14. doi request reprint [Staphylococcus aureus bacteremia and endocarditis]
    J C Lagier
    Service de Maladies Infectieuses et Tropicales, CHU de Nancy, 54511 Vandoeuvre les Nancy Cedex, France
    Ann Cardiol Angeiol (Paris) 57:71-7. 2008
    ..Other antibiotics such as fosfomycin, rifampicin, fusidic acid, or clindamycin can be used when aminosides are contra-indicated. The role of newer antibiotic agents, such as daptomycin or linezolide, remains to be established...
  15. ncbi request reprint [A new town-hospital network for antibiotherapy: ANTIBIOLOR]
    C Burty
    Service de Maladies Infectieuses et Tropicales, Hopital Brabois, Vandoeuvre les Nancy, France
    Med Mal Infect 35:S137-9. 2005
  16. ncbi request reprint [Study of 12 epidemical cases of legionnaire's disease occurred in Meurthe-et-Moselle (France) between July and August 2004]
    F Duhoux
    Département de Maladies Infectieuses et Tropicales, Tour Drouet, Hopitaux de Brabois, rue du Morvan, 54500 Vandoeuvre les Nancy, France
    Pathol Biol (Paris) 53:511-5. 2005
    ..To describe epidemiological, clinical, biological, radiological data and therapeutic features of legionnaire's disease during an outbreak occurring in Meurthe-et-Moselle between July-August 2004...
  17. doi request reprint Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study
    Tristan Ferry
    Service de Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Hopital de la Croix Rousse, Universite Claude Bernard Lyon 1, Lyon, France
    J Acquir Immune Defic Syndr 51:407-15. 2009
    ..To determine risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term combination antiretroviral therapy (cART)...
  18. doi request reprint Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France
    H Jeulin
    CHU Nancy, Laboratoire de Virologie, Nancy, F 54000, France Université Lorraine, Faculte de Medecine, EA 7300, Vandoeuvre les Nancy, F 54500, France
    J Antimicrob Chemother 69:3095-102. 2014
    ..To assess the prevalence of resistance to rilpivirine and mutations at position 138 in reverse transcriptase and to identify associated epidemiological and biological characteristics...
  19. ncbi request reprint [Two cases of spondylodiscitis due to Candida sp]
    E Frentiu
    Service de Maladies Infectieuses et Tropicales, Hopitaux de Brabois, CHU de Nancy, Allee du Morvan, 54511 Vandoeuvre les Nancy, France
    Med Mal Infect 37:275-80. 2007
    ..Surgical treatment is recommended only to patients ay risk of neurological disorders or severe epidural abscess...
  20. doi request reprint Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial
    Claudine Duvivier
    AP HP, Groupe Hospitalier Pitie Salpetriere, Service de Maladies Infectieuses et Tropicales, Paris F 75013, France
    J Antimicrob Chemother 62:797-808. 2008
    ..The aim of this study was to evaluate the impact on body fat of nucleoside reverse transcriptase inhibitor (NRTI)-sparing regimens compared with NRTI-containing therapy in HIV-1-infected antiretroviral (ARV)-naive patients...
  21. doi request reprint Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy
    S Grabar
    Department of Public Health, Cochin Hospital, Paris, France
    HIV Med 9:246-56. 2008
    ....
  22. ncbi request reprint [Predictive factors of virological response to primary antiretroviral treatment]
    J F Faucher
    CISIH de Besançon
    Presse Med 33:310-5. 2004
    ....
  23. doi request reprint Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic)
    Charlotte Lewden
    INSERM, U897, Bordeaux, France
    J Acquir Immune Defic Syndr 48:590-8. 2008
    ..The multicenter national Mortalité 2005 survey aimed at describing the distribution of causes of death among HIV-infected adults in France in 2005 and its changes as compared with 2000...
  24. ncbi request reprint [Community-acquired acute maxillary sinusitis or rhinosinusitis in adults in France: current management]
    J M Klossek
    Service ORL, CHU hôpital Jean Bernard, Poitiers
    Presse Med 34:1755-63. 2005
    ..This treatment is probabilistic, should be decided at the end of the consultation, and follows the AFSSAPS guidelines...
  25. ncbi request reprint [Mental health of HIV-positive women in France in the era of antiretroviral therapies: what differences between men and women? What is at stake?]
    Marie Preau
    LabECD, Universite de Nantes, Nantes
    Med Sci (Paris) 24:151-60. 2008
  26. ncbi request reprint [Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)]
    C Lewden
    INSERM U593 exU330, 146, rue Leo Saignat, 33076 Bordeaux Cedex, France
    Med Mal Infect 34:286-92. 2004
    ..The survey "Mortality 2000" had for aim to describe the distribution of causes of death in HIV-infected adults in France...
  27. ncbi request reprint [Infectious complications and misuse of high-dose buprenorphine]
    C Cazorla
    Service des Maladies Infectieuses et Tropicales, CHU de Nancy 54
    Presse Med 34:719-24. 2005
    ..Continued heroin injection by patients on HDB maintenance treatment and even HDB injection remain underestimated and may lead to a variety of infectious diseases...
  28. pmc Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation
    C Lewden
    INSERM U593, ISPED, Bordeaux, France
    Epidemiol Infect 134:1345-52. 2006
    ....
  29. ncbi request reprint Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study
    V Reliquet
    Service des Maladies Infectieuses et Tropicales, Hopital Hotel Dieu, Nantes, France
    HIV Med 7:431-6. 2006
    ..The aim of this study was to evaluate the long-term efficacy and safety of one or two daily doses of nevirapine (NVP), in combination with stavudine (d4T) and didanosine (ddI), in HIV-infected patients...
  30. ncbi request reprint Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment
    E Pukenyte
    Department of Infectious Diseases, Centre Hospitalier de Tourcoing, Tourcoing, France
    Int J Tuberc Lung Dis 11:78-84. 2007
    ....
  31. ncbi request reprint [Prof. Philippe Canton passed away this Thursday, September 6th, after a long disease]
    T May
    Med Mal Infect 37:S151-2. 2007
  32. ncbi request reprint Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapy
    Marie Preau
    Laboratory of Psychology, Laboratoire Education Cognition et Développement, Nantes University, Nantes, France
    J Acquir Immune Defic Syndr 47:467-71. 2008
    ..We studied the evolution of the patient-provider relationship (PPR) in HIV-infected patients who reported trustful relationships at highly active antiretroviral therapy (HAART) treatment initiation...
  33. doi request reprint Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy
    Christophe Piketty
    AP HP, Department of Clinical Immunology, Georges Pompidou European Hospital, Rene Descartes University, Paris, France
    AIDS 22:1203-11. 2008
    ..To describe the cases of anal cancer that appeared in the French Hospital Database on HIV between 1992 and 2004 and to study risk factors of anal cancer...
  34. ncbi request reprint Assessment by flow cytometry of peripheral blood leukocyte enzymatic activities in HIV patients
    C Prin-Mathieu
    Laboratoire d'Immunologie, , , F-54500 Vandoeuvre les, Nancy, France
    J Immunol Methods 252:139-46. 2001
    ..Significant variations were observed in the peripheral blood of HIV-infected patients and different patterns were especially evident in monocytes and polymorphonuclear cells...